214 related articles for article (PubMed ID: 34669958)
1. Broadening the reach and investigating the potential of prime editors through fully viral gene-deleted adenoviral vector delivery.
Wang Q; Liu J; Janssen JM; Tasca F; Mei H; Gonçalves MAFV
Nucleic Acids Res; 2021 Nov; 49(20):11986-12001. PubMed ID: 34669958
[TBL] [Abstract][Full Text] [Related]
2. In vivo somatic cell base editing and prime editing.
Newby GA; Liu DR
Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral Vectors Meet Gene Editing: A Rising Partnership for the Genomic Engineering of Human Stem Cells and Their Progeny.
Tasca F; Wang Q; Gonçalves MAFV
Cells; 2020 Apr; 9(4):. PubMed ID: 32295080
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
5. High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of
Brescia M; Janssen JM; Liu J; Gonçalves MAFV
Cells; 2020 Apr; 9(4):. PubMed ID: 32252479
[TBL] [Abstract][Full Text] [Related]
6. Key to Delivery: The (Epi-)genome Editing Vector Toolbox.
Just S; Büning H
Methods Mol Biol; 2018; 1767():147-166. PubMed ID: 29524133
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.
Ehrke-Schulz E; Schiwon M; Leitner T; Dávid S; Bergmann T; Liu J; Ehrhardt A
Sci Rep; 2017 Dec; 7(1):17113. PubMed ID: 29215041
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus vectors in hematopoietic stem cell genome editing.
Li C; Lieber A
FEBS Lett; 2019 Dec; 593(24):3623-3648. PubMed ID: 31705806
[TBL] [Abstract][Full Text] [Related]
9. In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector.
Lorincz R; Alvarez AB; Walkey CJ; Mendonça SA; Lu ZH; Martinez AE; Ljungberg C; Heaney JD; Lagor WR; Curiel DT
Biomed Pharmacother; 2023 Feb; 158():114189. PubMed ID: 36587560
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells.
Holkers M; Cathomen T; Gonçalves MA
Methods; 2014 Sep; 69(2):179-87. PubMed ID: 24561826
[TBL] [Abstract][Full Text] [Related]
11. A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines.
Eggenschwiler R; Gschwendtberger T; Felski C; Jahn C; Langer F; Sterneckert J; Hermann A; Lühmann J; Steinemann D; Haase A; Martin U; Petri S; Cantz T
Sci Rep; 2021 Nov; 11(1):22154. PubMed ID: 34773059
[TBL] [Abstract][Full Text] [Related]
12. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.
Holkers M; Maggio I; Liu J; Janssen JM; Miselli F; Mussolino C; Recchia A; Cathomen T; Gonçalves MA
Nucleic Acids Res; 2013 Mar; 41(5):e63. PubMed ID: 23275534
[TBL] [Abstract][Full Text] [Related]
13. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
Tang L; Gong M; Zhang P
Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
15. Nonintegrating Gene Therapy Vectors.
Athanasopoulos T; Munye MM; Yáñez-Muñoz RJ
Hematol Oncol Clin North Am; 2017 Oct; 31(5):753-770. PubMed ID: 28895845
[TBL] [Abstract][Full Text] [Related]
16. Stability of adenoviral vectors following catheter delivery.
Tsui LV; Zayek N; Frey D; Mello C; Banik G; Falotico R; McArthur JG
Mol Ther; 2001 Jan; 3(1):122-5. PubMed ID: 11162319
[TBL] [Abstract][Full Text] [Related]
17. Precise plant genome editing using base editors and prime editors.
Molla KA; Sretenovic S; Bansal KC; Qi Y
Nat Plants; 2021 Sep; 7(9):1166-1187. PubMed ID: 34518669
[TBL] [Abstract][Full Text] [Related]
18. GMP-Compliant Adenoviral Vectors for Gene Therapy.
Arjmand B; Alavi-Moghadam S; Payab M; Goodarzi P; Sheikh Hosseini M; Tayanloo-Beik A; Rezaei-Tavirani M; Larijani B
Methods Mol Biol; 2021; 2286():237-250. PubMed ID: 32504293
[TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticle-Enabled Intracellular Delivery of Prime Editors.
Herrera-Barrera M; Gautam M; Lokras A; Vlasova K; Foged C; Sahay G
AAPS J; 2023 Jun; 25(4):65. PubMed ID: 37380935
[TBL] [Abstract][Full Text] [Related]
20. PEAR, a flexible fluorescent reporter for the identification and enrichment of successfully prime edited cells.
Simon DA; Tálas A; Kulcsár PI; Biczók Z; Krausz SL; Várady G; Welker E
Elife; 2022 Feb; 11():. PubMed ID: 35196219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
